Invesco Dynamic Pharmaceuticals ETF (NYSEARCA:PJP) Shares Bought by Cambridge Investment Research Advisors Inc.

Cambridge Investment Research Advisors Inc. lifted its position in Invesco Dynamic Pharmaceuticals ETF (NYSEARCA:PJP) by 8.9% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 19,404 shares of the company’s stock after acquiring an additional 1,585 shares during the period. Cambridge Investment Research Advisors Inc. owned 0.29% of Invesco Dynamic Pharmaceuticals ETF worth $1,167,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also recently modified their holdings of PJP. Hanson McClain Inc. purchased a new stake in shares of Invesco Dynamic Pharmaceuticals ETF in the 2nd quarter valued at $30,000. Pacific Sun Financial Corp purchased a new stake in shares of Invesco Dynamic Pharmaceuticals ETF in the 2nd quarter valued at $677,000. Envestnet Asset Management Inc. raised its holdings in shares of Invesco Dynamic Pharmaceuticals ETF by 1,083.3% in the 2nd quarter. Envestnet Asset Management Inc. now owns 186,707 shares of the company’s stock valued at $11,232,000 after buying an additional 170,928 shares during the period. JPMorgan Chase & Co. raised its holdings in shares of Invesco Dynamic Pharmaceuticals ETF by 7.4% in the 2nd quarter. JPMorgan Chase & Co. now owns 10,846 shares of the company’s stock valued at $647,000 after buying an additional 746 shares during the period. Finally, Advisory Services Network LLC raised its holdings in shares of Invesco Dynamic Pharmaceuticals ETF by 474.9% in the 2nd quarter. Advisory Services Network LLC now owns 2,587 shares of the company’s stock valued at $156,000 after buying an additional 2,137 shares during the period.

NYSEARCA PJP traded up $0.58 during trading hours on Friday, hitting $56.52. 38,482 shares of the company were exchanged, compared to its average volume of 35,999. The company has a 50 day moving average of $56.63 and a two-hundred day moving average of $59.42. Invesco Dynamic Pharmaceuticals ETF has a 52-week low of $54.86 and a 52-week high of $70.89.

The business also recently declared a — dividend, which was paid on Monday, September 30th. Shareholders of record on Tuesday, September 24th were issued a dividend of $0.1492 per share. The ex-dividend date was Monday, September 23rd. This represents a yield of 1.2%.

Invesco Dynamic Pharmaceuticals ETF Company Profile

PowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors.

Featured Article: What is a short straddle?

Institutional Ownership by Quarter for Invesco Dynamic Pharmaceuticals ETF (NYSEARCA:PJP)

Receive News & Ratings for Invesco Dynamic Pharmaceuticals ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invesco Dynamic Pharmaceuticals ETF and related companies with MarketBeat.com's FREE daily email newsletter.